Browsing by Author Margelí Vila, Mireia
Showing results 4 to 9 of 9
< previous
| Issue Date | Title | Author(s) |
|---|---|---|
| 27-Jan-2022 | Modulation of DNA damage response by SAM and HD Domain containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) determines prognosis and treatment efficacy in different solid tumor types | Felip, Eudald; Gutiérrez-Chamorro, Lucía; Gómez, Maica; Garcia-Vidal, Edurne; Romeo, Margarita; Morán, Teresa; Layos, Laura; Pérez-Roca, Laia; Riveira-Muñoz, Eva; Clotet, Bonaventura, 1953-; Fernández, Pedro Luis; Mesía Nin, Ricard; Martínez Cardús, Anna; Ballana, Ester; Margelí Vila, Mireia |
| 1-Apr-2021 | Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL | Martin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel |
| 11-Jul-2024 | Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response | Brasó-maristany, Fara; Ferrero-cafiero, Juan Manuel; Falato, Claudette; Martínez Sáez, Olga; Cejalvo, Juan Miguel; Margelí Vila, Mireia; Tolosa, Pablo; Salvador-bofill, Francisco Javier; Cruz, Josefina; González-farré, Blanca; Sanfeliu, Esther; Òdena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana María; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sánchez Bayona, Rodrigo; Ciruelos, Eva; Espinosa-bravo, Martín; Izarzugaza, Yann; Galván, Patricia; Matito, Judit; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomás; Prat, Aleix; Oliveira, Mafalda |
| 6-Sep-2012 | Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a restrospective cohort study in Catalonia, Spain. | Font, Rebeca; Espinàs Piñol, Josep Alfons; Gil Gil, Miguel; Barnadas i Molins, Agustí; Ojeda, B.; Tusquets, Ignasi; Seguí, Miquel A.; Margelí Vila, Mireia; Arcusa, Angels; Prat Marín, Andrés; García, M.; Borràs Andrés, Josep Maria |
| 2020 | Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer | Margelí Vila, Mireia; Del Barco Berron, S.; Gil-Gil, M.; Ochoa Arnedo, Cristian; Villanueva Vazquez, R. |
| 23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |